Role of anoctamins in cancer and apoptosis |
| |
Authors: | Podchanart Wanitchakool Luisa Wolf Gudrun E. Koehl Lalida Sirianant Rainer Schreiber Sucheta Kulkarni Umamaheswar Duvvuri Karl Kunzelmann |
| |
Affiliation: | 1.Institut für Physiologie, Universität Regensburg, Universitätsstraße 31, Regensburg 93053, Germany;2.Department of Surgery, University Medical Center Regensburg, University of Regensburg, Regensburg, Germany;3.Ear & Eye Institute, University of Pittsburgh Medical Center, University of Pittsburgh School of Medicine, Pittsburgh, PA 15213, USA |
| |
Abstract: | Anoctamin 1 (TMEM16A, Ano1) is a recently identified Ca2+-activated chloride channel and a member of a large protein family comprising 10 paralogues. Before Ano1 was identified as a chloride channel protein, it was known as the cancer marker DOG1. DOG1/Ano1 is expressed in gastrointestinal stromal tumours (GIST) and particularly in head and neck squamous cell carcinoma, at very high levels never detected in other tissues. It is now emerging that Ano1 is part of the 11q13 locus, amplified in several types of tumour, where it is thought to augment cell proliferation, cell migration and metastasis. Notably, Ano1 is upregulated through histone deacetylase (HDAC), corresponding to the known role of HDAC in HNSCC. As Ano1 does not enhance proliferation in every cell type, its function is perhaps modulated by cell-specific factors, or by the abundance of other anoctamins. Thus Ano6, by regulating Ca2+-induced membrane phospholipid scrambling and annexin V binding, supports cellular apoptosis rather than proliferation. Current findings implicate other cellular functions of anoctamins, apart from their role as Ca2+-activated Cl− channels. |
| |
Keywords: | anoctamin 1 anoctamin 6 TMEM16A TMEM16F cancer head and neck stromal cell carcinoma |
|
|